P648: REAL‐WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST‐LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY

Bibliographische Detailangaben

Veröffentlicht in:	HemaSphere 2023-08, Vol.7 (S3), p.e6855326-n/a
Hauptverfasser:	Lansigan, Frederick, A. Eyre, Toby, Ghosh, Nilanjan, S. Manzoor, Beenish, C. Coombs, Catherine, Lamanna, Nicole, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, E. Roeker, Lindsey, Ujjani, Chaitra, Alhasani, Hasan, Fleury, Isabelle, A. Leslie, Lori, Skarbnik, Alan, Rhodes, Joanna, T. Hill, Brian, M. Barr, Paul, S. Davids, Matthew, P. Fox, Christopher, Choi, Yun, Schuh, Anna, Kennard, Kaitlin, E. Jensen, Christopher, Jawaid, Dureshahwar, Sharma, Aditya, Pivneva, Irina, Watson, Talissa, Shadman, Mazyar
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!